Age for routine administration of the second dose of measles-mumps-rubella vaccine
Age for routine administration of the second dose of measles-mumps-rubella vaccine
复制标题
DOI：
10.1542/peds.101.1.129
复制
发表时间：
1998-01-01
期刊：
影响因子：
8
通讯作者：
Rabinovich, NR
中科院分区：
文献类型：
--
作者：
Halsey, NA;Abramson, JS;Rabinovich, NR
本声明的目的是告知医生关于常规接种第二剂麻疹-腮腺炎-风疹 (MMR) 疫苗的适当年龄建议的修改。两剂麻疹疫苗接种计划的实施改善了麻疹的控制，但尽管有大于或等于95%的在校儿童接种了电影剂量的疫苗，但一些麻疹疫情仍在学童中发生。由于大多数麻疹疫苗失败是由于对第一剂疫苗没有反应，因此所有儿童都接受两剂含麻疹疫苗对于控制麻疹至关重要。在入学时（4 至 6 岁）常规接种第二剂 MMR 疫苗将有助于预防学校内的疫情爆发。医生应继续审查所有 11 至 12 岁儿童的记录，以确保他们在一岁生日后接种了两剂 MMR 疫苗。记录到 2001 年所有学童已接种两剂含麻疹疫苗的情况将有助于确保在美国消除麻疹，并为全球控制和可能根除麻疹的努力作出贡献。
The purpose of this statement is to inform physicians of a modification in the recommendation of the appropriate age for routine administration of the second dose of measles-mumps-rubella (MMR) vaccine. The implementation of the two-dose measles vaccine schedule has improved the control of measles, but some outbreaks continue to occur in school children, although greater than or equal to 95% of children in school have received cine dose of vaccine. Because most measles vaccine failures are attributable to failure to respond to the first dose, that all children receive two doses of measles-containing vaccine is essential for the control of measles. Routine administration of the second dose of MMR vaccine at school entry (4 to 6 years of age) will help prevent school-based outbreaks. Physicians should continue to review the records of all children 11 to 12 years of age to be certain that they have received two doses of MMR vaccine after their first birthday. Documenting that all school children have received two doses of measles-containing vaccine by the year 2001 will help ensure the elimination of measles in the United States and contribute to the global effort to control and possibly eradicate measles.